BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 26411859)

  • 1. Treatment of intrabony defects with guided tissue regeneration in aggressive periodontitis: clinical outcomes at 6 and 12 months.
    Rakmanee T; Griffiths GS; Auplish G; Darbar U; Petrie A; Olsen I; Donos N
    Clin Oral Investig; 2016 Jul; 20(6):1217-25. PubMed ID: 26411859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiographic outcomes following treatment of intrabony defect with guided tissue regeneration in aggressive periodontitis.
    Rakmanee T; Griffiths GS; Auplish G; Darbar U; Petrie A; Olsen I; Donos N
    Clin Oral Investig; 2016 Jul; 20(6):1227-35. PubMed ID: 26452978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of intrabony defects with anorganic bone matrix/p-15 or guided tissue regeneration in patients with aggressive periodontitis.
    Queiroz AC; Nóbrega PB; Oliveira FS; Novaes AB; Taba M; Palioto DB; Grisi MF; Souza SL
    Braz Dent J; 2013; 24(3):204-12. PubMed ID: 23969907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of intrabony defects using guided tissue regeneration or enamel matrix derivative: a 3-year prospective randomized clinical study.
    Crea A; Dassatti L; Hoffmann O; Zafiropoulos GG; Deli G
    J Periodontol; 2008 Dec; 79(12):2281-9. PubMed ID: 19053918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of deep and shallow intrabony defects. A multicenter randomized controlled clinical trial.
    Cortellini P; Carnevale G; Sanz M; Tonetti MS
    J Clin Periodontol; 1998 Dec; 25(12):981-7. PubMed ID: 9869347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of intrabony defects with modified perforated membranes in aggressive periodontitis: a 12-month randomized controlled trial.
    Górski B; Jalowski S; Górska R; Zaremba M
    Clin Oral Investig; 2018 Nov; 22(8):2819-2828. PubMed ID: 29411112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generalizability of the added benefits of guided tissue regeneration in the treatment of deep intrabony defects. Evaluation in a multi-center randomized controlled clinical trial.
    Tonetti MS; Cortellini P; Suvan JE; Adriaens P; Baldi C; Dubravec D; Fonzar A; Fourmousis I; Magnani C; Muller-Campanile V; Patroni S; Sanz M; Vangsted T; Zabalegui I; Pini Prato G; Lang NP
    J Periodontol; 1998 Nov; 69(11):1183-92. PubMed ID: 9848527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes after treatment of non-contained intrabony defects with enamel matrix derivative or guided tissue regeneration: a 12-month randomized controlled clinical trial.
    Siciliano VI; Andreuccetti G; Siciliano AI; Blasi A; Sculean A; Salvi GE
    J Periodontol; 2011 Jan; 82(1):62-71. PubMed ID: 20809859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The simplified papilla preservation flap in the regenerative treatment of deep intrabony defects: clinical outcomes and postoperative morbidity.
    Cortellini P; Tonetti MS; Lang NP; Suvan JE; Zucchelli G; Vangsted T; Silvestri M; Rossi R; McClain P; Fonzar A; Dubravec D; Adriaens P
    J Periodontol; 2001 Dec; 72(12):1702-12. PubMed ID: 11811506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of intrabony defects with modified perforated membranes in aggressive periodontitis: a 4-year follow-up of a randomized controlled trial.
    Górski B; Jalowski S; Górska R; Zaremba M
    Clin Oral Investig; 2020 Mar; 24(3):1183-1196. PubMed ID: 31324986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of intrabony defects with enamel matrix proteins or barrier membranes: results from a multicenter practice-based clinical trial.
    Sanz M; Tonetti MS; Zabalegui I; Sicilia A; Blanco J; Rebelo H; Rasperini G; Merli M; Cortellini P; Suvan JE
    J Periodontol; 2004 May; 75(5):726-33. PubMed ID: 15212355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes following treatment of human intrabony defects with GTR/bone replacement material or access flap alone. A multicenter randomized controlled clinical trial.
    Tonetti MS; Cortellini P; Lang NP; Suvan JE; Adriaens P; Dubravec D; Fonzar A; Fourmousis I; Rasperini G; Rossi R; Silvestri M; Topoll H; Wallkamm B; Zybutz M
    J Clin Periodontol; 2004 Sep; 31(9):770-6. PubMed ID: 15312100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GTR treatment of intrabony defects in patients with early-onset and chronic adult periodontitis.
    Zucchelli G; Brini C; De Sanctis M
    Int J Periodontics Restorative Dent; 2002 Aug; 22(4):323-33. PubMed ID: 12212679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deproteinized bovine bone in association with guided tissue regeneration or enamel matrix derivatives procedures in aggressive periodontitis patients: a 1-year retrospective study.
    Artzi Z; Tal H; Platner O; Wasersprung N; Weinberg E; Slutzkey S; Gozali N; Carmeli G; Herzberg R; Kozlovsky A
    J Clin Periodontol; 2015 Jun; 42(6):547-56. PubMed ID: 25950086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel marginal periosteal pedicle graft as an autogenous guided tissue membrane for the treatment of intrabony periodontal defects.
    Gamal AY; Mailhot JM
    J Int Acad Periodontol; 2008 Oct; 10(4):106-17. PubMed ID: 19055224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enamel matrix proteins and guided tissue regeneration with titanium-reinforced expanded polytetrafluoroethylene membranes in the treatment of infrabony defects: a comparative controlled clinical trial.
    Zucchelli G; Bernardi F; Montebugnoli L; De SM
    J Periodontol; 2002 Jan; 73(1):3-12. PubMed ID: 11846197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of platelet-rich plasma, bovine porous bone mineral, and guided tissue regeneration versus platelet-rich plasma and bovine porous bone mineral in the treatment of intrabony defects: a reentry study.
    Lekovic V; Camargo PM; Weinlaender M; Vasilic N; Kenney EB
    J Periodontol; 2002 Feb; 73(2):198-205. PubMed ID: 11895286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five-year clinical results for treatment of intrabony defects with EMD, guided tissue regeneration and open-flap debridement: a case series.
    Mitani A; Takasu H; Horibe T; Furuta H; Nagasaka T; Aino M; Fukuda M; Fujimura T; Mogi M; Noguchi T
    J Periodontal Res; 2015 Feb; 50(1):123-30. PubMed ID: 24815103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of enamel matrix proteins and bioabsorbable membranes in the treatment of intrabony periodontal defects. A split-mouth study.
    Sculean A; Donos N; Blaes A; Lauermann M; Reich E; Brecx M
    J Periodontol; 1999 Mar; 70(3):255-62. PubMed ID: 10225541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autogenous periosteal barrier membranes and bone grafts in the treatment of periodontal intrabony defects of single-rooted teeth: a 12-month reentry randomized controlled clinical trial.
    Paolantonio M; Femminella B; Coppolino E; Sammartino G; D'Arcangelo C; Perfetti G; Perinetti G
    J Periodontol; 2010 Nov; 81(11):1587-95. PubMed ID: 20583915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.